Provided by Tiger Trade Technology Pte. Ltd.

Biocryst Pharmaceuticals

7.61
+0.20002.70%
Pre-market: 7.660.0500+0.66%05:01 EST
Volume:3.55M
Turnover:26.98M
Market Cap:1.60B
PE:-167.92
High:7.69
Open:7.40
Low:7.35
Close:7.41
52wk High:11.31
52wk Low:6.00
Shares:210.74M
Float Shares:207.69M
Volume Ratio:0.78
T/O Rate:1.71%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.0453
EPS(LYR):-0.4300
ROE:587.33%
ROA:10.31%
PB:-4.13
PE(LYR):-17.70

Loading ...

BioCryst Pharmaceuticals Inc: Lowering Its Outlook for 2025 Adj Operating Expenses to Between $430 Mln and $440 Mln

THOMSON REUTERS
·
Nov 03

BioCryst Pharmaceuticals Inc: Company Remains on Track to Deliver Net Income and Positive Cash Flows for Full Year 2025

THOMSON REUTERS
·
Nov 03

BioCryst Pharmaceuticals Q3 Operating Expenses USD 129.804 Million

THOMSON REUTERS
·
Nov 03

Stock Track | BioCryst Pharmaceuticals (BCRX) Surges 5.33% Pre-Market Ahead of Q3 Earnings Report

Stock Track
·
Nov 03

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Nov 03

Assessing BioCryst Pharmaceuticals (BCRX) Valuation After Recent Modest Share Price Uptick

Simply Wall St.
·
Nov 03

A Closer Look at BioCryst Pharmaceuticals (BCRX) Valuation After Recent Share Price Movement

Simply Wall St.
·
Oct 25

BioCryst to Present New Pediatric Hae Data at the American College of Allergy, Asthma & Immunology 2025 Annual Scientific Meeting

THOMSON REUTERS
·
Oct 23

BioCryst Unveils Positive Pediatric HAE Data for Oral Berotralstat at ACAAI 2025

Reuters
·
Oct 23

Bicara sinks after J&J reports head and neck cancer data

TIPRANKS
·
Oct 21

BioCryst price target raised to $26 from $24 at Cantor Fitzgerald

TIPRANKS
·
Oct 15

RBC Raises Price Target on BioCryst Pharmaceuticals to $15 From $14, Keeps Outperform Rating

MT Newswires Live
·
Oct 15

BioCryst Pharmaceuticals Is Maintained at Buy by Needham

Dow Jones
·
Oct 15

U.S. RESEARCH ROUNDUP- BlackRock, EQT, Ovintiv

Reuters
·
Oct 15

BioCryst Pharmaceuticals Inc : TD Cowen Reinstates Coverage With Buy Rating; Target Price $30

THOMSON REUTERS
·
Oct 15

BioCryst reinstated with a Buy at TD Cowen

TIPRANKS
·
Oct 15

RBC Capital Reaffirms Their Buy Rating on BioCryst (BCRX)

TIPRANKS
·
Oct 15

BioCryst price target raised to $15 from $14 at Jefferies

TIPRANKS
·
Oct 15

BioCryst Pharmaceuticals Down Over 10%, on Track for Lowest Close Since June 2024 -- Data Talk

Dow Jones
·
Oct 15

BUZZ-U.S. STOCKS ON THE MOVE-Spyre Therapeutics, Astria, Walmart

Reuters
·
Oct 15